The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1414-1418 , June 2007

Ten traps for the unwary in surgical series: A case study in mesothelioma reports

  • Tom Treasure, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Guy’s Hospital, London, United Kingdom
    • Corresponding Author InformationAddress for reprints: Tom Treasure, Professor of Cardiothoracic Surgery, Guy’s Hospital, London, United Kingdom.
    • ,
  • Martin Utley, PhD

      Affiliations

    • Clinical Operational Research Unit, University College London, London, United Kingdom.

Received 31 October 2006 ,Revised 31 January 2007 ,Accepted 12 February 2007.

References 

  1. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005;92:587–593
  2. Treasure T, Sedrakyan A. Pleural mesothelioma: little evidence, still time to do trials. Lancet. 2004;364:1183–1185
  3. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura (Experience with 29 patients). Thorax. 1976;31:15–24
  4. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636–2644
  5. Treasure T, Waller D, Swift S, Peto J. Radical surgery for mesothelioma. BMJ. 2004;328:237–238
  6. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54–63
  7. Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2001;122:788–795
  8. Tan C, Swift S, Gilham C, Shaefi S, Fountain SW, Peto J, et al. Survival in surgically diagnosed patients with malignant mesothelioma in current practice. [abstract] Thorax. 2002;57iii:36
  9. Su S, Jaklitsch M, Sugarbaker D. Treatment of malignant pleural mesothelioma: is there a benefit to pleuropneumonectomy?. In:  Ferguson M editors. Difficult decisions in thoracic surgery: an evidence based approach. London: Springer-Verlag; 2007;p. 451–460
  10. http:/www.brighamandwomens.org/excellence/COEsissy.aspx One patient’s story: Sissy. http://www.brighamandwomens.org/excellence/COEsissy.aspx [2006 Nov 27].
  11. Flores R. Debate: surgery for malignant pleural mesothelioma: a guaranteed complete response. Lung Cancer. 2006;54(Suppl 1):S42
  12. Treasure T. The evidence on which to base practice: different tools for different times. Eur J Cardiothorac Surg. 2006;30:819–824
  13. Treasure T. From anecdote to EBM. J R Soc Med. 2006;99:267–270
  14. Kumar A, Soares H, Wells R, Clarke M, Hozo I, Bleyer A, et al. Are experimental treatments for cancer in children superior to established treatments? (Observational study of randomised controlled trials by the Children’s Oncology Group). BMJ. 2005;331:1295

PII: S0022-5223(07)00365-0

doi: 10.1016/j.jtcvs.2007.02.014

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1414-1418 , June 2007

Article Tools